Incremental doses of diltiazem in patients with coronary artery disease in end-stage renal failure maintained on hemodialysis: which is the optimal dose?;Diltiazem a dosaggi crescenti in pazienti uremici emodializzati con cardiopatia ischemica: qual è il dosaggio ottimale?

Cardiologia (Rome, Italy)

Volumn 43, Issue 12, 1998, Pages 1337-1343

  Cice, G ^a   Ferrara, L ^a   Tagliamonte, E ^a   Di Benedetto, A ^a   Iacono, A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM;

ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; FEMALE; HEART FUNCTION TEST; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

CALCIUM CHANNEL BLOCKERS; CORONARY DISEASE; DILTIAZEM; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART FUNCTION TESTS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0032242632     PISSN: 03931978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)